S100A6 and prostate adenocarcinoma: To our knowledge there is only one recent report investigating the tissue expression of S100A6 in prostatic adenocarcinoma, which showed that ∼20% of the cases arranged on a TMA had S100A6 expression (Hsieh et al, 2003).